Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in LEXX held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | Invenomic Capital Management LP | 442K | $345K | -6.1% | 1.990% | 0.02% |
| 2 | GEODE CAPITAL MANAGEMENT, LLC | 294K | $229K | +33.9% | 1.324% | 0.00% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 222K | $173K | β | 1.000% | 0.00% |
| 4 | TORONTO DOMINION BANK | 140K | $109K | 0.0% | 0.630% | 0.00% |
| 5 | VANGUARD FIDUCIARY TRUST CO | 94K | $73K | β | 0.424% | 0.00% |
| 6 | UBS Group AG | 53K | $41K | -85.4% | 0.237% | 0.00% |
| 7 | STATE STREET CORP | 39K | $31K | 0.0% | 0.177% | 0.00% |
| 8 | BlackRock, Inc. | 27K | $21K | 0.0% | 0.123% | 0.00% |
| 9 | XTX Topco Ltd | 25K | $20K | β | 0.113% | 0.00% |
| 10 | Krilogy Financial LLC | 20K | $19K | 0.0% | 0.088% | 0.00% |
| 11 | Vontobel Holding Ltd. | 23K | $18K | β | 0.103% | 0.00% |
| 12 | NORTHERN TRUST CORP | 18K | $14K | 0.0% | 0.083% | 0.00% |
| 13 | RENAISSANCE TECHNOLOGIES LLC | 16K | $13K | +4.5% | 0.073% | 0.00% |
| 14 | BANK OF MONTREAL /CAN/ | 14K | $11K | -0.4% | 0.063% | 0.00% |
| 15 | CITADEL ADVISORS LLC | 14K | $11K | β | 0.061% | 0.00% |
| 16 | Vanguard Global Advisers, LLC | 10K | $8K | β | 0.046% | 0.00% |
| 17 | BCV Asset Management Inc. | 10K | $8K | β | 0.045% | 0.00% |
| 18 | ROYAL BANK OF CANADA | 7K | $6K | -2.0% | 0.032% | 0.00% |
| 19 | Byrne Asset Management LLC | 800 | $624 | -99.2% | 0.004% | 0.00% |
| 20 | ADVISOR GROUP HOLDINGS, INC. | 605 | $471 | -72.4% | 0.003% | 0.00% |
| 21 | CITIGROUP INC | 489 | $381 | β | 0.002% | 0.00% |
| 22 | Federation des caisses Desjardins du Quebec | 382 | $298 | 0.0% | 0.002% | 0.00% |
| 23 | Farther Finance Advisors, LLC | 166 | $144 | 0.0% | 0.001% | 0.00% |
| 24 | HRT FINANCIAL LP | 18K | $14 | β | 0.083% | 0.00% |
| 25 | GABLES CAPITAL MANAGEMENT INC. | 13 | $10 | 0.0% | 0.000% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in LEXX β a direct measure of their conviction.
Filings activity in LEXX during Q1 2026, grouped by how each filer changed its position.
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 28 | +33% | 8.44% | +0.73 pp | $1M | +9.5% |
| Q4 2025 | 21 | 16% | 7.71% | 4.05 pp | $1M | 34% |
| Q3 2025 | 25 | +14% | 11.76% | 2.89 pp | $2M | 20% |
| Q2 2025 | 22 | 4.3% | 14.65% | 0.87 pp | $2M | 5.6% |
| Q1 2025 | 23 | 12% | 15.52% | 6.44 pp | $2M | 29% |
| Q4 2024 | 26 | 3.7% | 21.96% | 1.50 pp | $3M | 6.4% |
| Q3 2024 | 27 | 6.9% | 23.46% | 18.43 pp | $3M | 44% |
| Q2 2024 | 29 | β | 41.89% | β | $6M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying LEXX stock.
Based on Q1 2026 13F filings, institutional ownership of Lexaria Bioscience Corp. stands at 8.4%, held across 28 reporting institutions.
Invenomic Capital Management LP is the largest reported institutional holder of LEXX, with approximately 442,301 shares worth $0.00B as of Q1 2026.
Yes β 2 widely-followed marquee investors appear among the top 25 institutional holders of LEXX, including RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC.
Our composite Smart Money Score for LEXX is 69 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
10 institutions opened new positions in LEXX during Q1 2026, while 3 fully exited. 13 added to existing positions and 4 trimmed.
LEXX institutional ownership rose by 0.73 percentage points quarter-over-quarter, with a net change of +7 holders.
The top 10 institutions account for 92.2% of all reported 13F value in LEXX, and the top 25 account for 100.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Lexaria Bioscience Corp. (LEXX) Institutional Ownership